MYND Life Sciences Inc. (MYNDF)

USD 0.06

(0.0%)

Annual Income Statements

(In CAD)
Breakdown 2023 2022 2021 2020 2019
Revenue 92.99 Thousand - - - -
Cost of Revenue 332.99 Thousand 180 Thousand - - -
Gross Profit -240 Thousand -180 Thousand - - -
Operating Expenses 1.58 Million 2.88 Million 4.29 Million 56.46 Thousand 2535.00
Selling, General and Administrative Expenses 1.18 Million 1.51 Million 3.12 Million 56.46 Thousand 2535.00
Research and Development Expenses 282.27 Thousand 1.18 Million 1.07 Million - -
Other Expenses 121.37 Thousand 14.38 Thousand - - -
Cost and Expenses 1.82 Million 3.06 Million 4.29 Million 56.46 Thousand 2535.00
Operating Income -1.82 Million -3.72 Million -4.29 Million -56.46 Thousand -2535.00
Interest Expense 731.75 Thousand 662.9 Thousand 134.88 Thousand - -
Income Tax Expense - -129.94 Thousand -168.3 Thousand - -
Earnings before Tax -1.51 Million -3.69 Million -4.53 Million -56.46 Thousand -2535.00
Net Income -1.51 Million -3.56 Million -4.36 Million -56.46 Thousand -2535.00
Earnings Per Share Basic -0.03 -0.08 -0.10 -0.00 -0.00
Earnings Per Share Diluted -0.03 -0.08 -0.10 -0.00 -0.00
Weighted Average Shares Outstanding 47.27 Million 46.67 Million 44.95 Million 28.23 Million 1.7 Million
Weighted Average Shares Outstanding (Diluted) 47.26 Million 46.67 Million 44.95 Million 28.22 Million 1.7 Million
Gross Margin -2.58 - - - -
EBIT Margin -19.63 - - - -
Profit Margin -16.32 - - - -
EBITDA -1.82 Million -2.98 Million -4.28 Million - -
Earnings Before Tax Margin -19.67 - - - -

Income Statement Charts